GSK2292767
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2292767, covering 2019-05-28 to 2019-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes [Phase 1]